JUBYVI Trademark

Trademark Overview

On Monday, March 9, 2026, a trademark application was filed for JUBYVI with the United States Patent and Trademark Office. The USPTO has given the JUBYVI trademark a serial number of 99691878. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, July 14, 2026. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The JUBYVI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the fields of antisense oligonucleotides, nucleic acid-targeted therapeutics, and neuro-genetic, genetic, and neurological diseases and disorders; providing medical and scientific research and medical and scientific research information in the fields of antisense oligonucleotides, nucleic acid-targeted therapeutics, and neuro-genetic, genetic, and neurological diseases and disorders; compiling data for research purposes in the fields of antisense oligonucleotides, nucleic acid-targeted therapeutics, and neuro-genetic, genetic, and neurological diseases and disorders
jubyvi

General Information

Serial Number99691878
Word MarkJUBYVI
Filing DateMonday, March 9, 2026
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, July 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical research and development in the fields of antisense oligonucleotides, nucleic acid-targeted therapeutics, and neuro-genetic, genetic, and neurological diseases and disorders; providing medical and scientific research and medical and scientific research information in the fields of antisense oligonucleotides, nucleic acid-targeted therapeutics, and neuro-genetic, genetic, and neurological diseases and disorders; compiling data for research purposes in the fields of antisense oligonucleotides, nucleic acid-targeted therapeutics, and neuro-genetic, genetic, and neurological diseases and disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 9, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
US

Trademark Events

Event DateEvent Description
Monday, March 9, 2026NEW APPLICATION ENTERED
Monday, March 9, 2026APPLICATION FILING RECEIPT MAILED
Tuesday, July 7, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 9, 2026ASSIGNED TO EXAMINER
Tuesday, July 14, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

jubyvi genetic research neurological therapeutics diseases disorders targeted neuro fields acid